Search

everythinglearnresearchcommunity

for

Search:↓

New 5% minoxidil foam effectively promotes hair growth and is safe for use.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

New treatments for male hypogonadism are effective and should be personalized.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Birth control pills can help reduce mild to moderate acne in women.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Creatine monohydrate is safe and effective for muscle recovery and performance, especially for those with low creatine levels.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Taking sildenafil and finasteride together is safe and improves urinary and sexual symptoms in BPH patients.

Taking oral testosterone with finasteride or dutasteride doubles testosterone levels, and food slightly affects it.

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

Combining finasteride with dimethyl-β-cyclodextrin improves its absorption and bioavailability.

Accurate method measures finasteride levels in human plasma using gas chromatography-mass spectrometry.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

PFAS exposure in adolescence may delay puberty in females.

Saw palmetto can help with prostate issues and may promote hair growth.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.